These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11054389)

  • 21. Budesonide in the first line treatment of patients with autoimmune hepatitis.
    Olivas I; Cobreros M; Londoño MC; Díaz-González Á
    Gastroenterol Hepatol; 2022; 45(7):561-570. PubMed ID: 34923033
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis and management of autoimmune hepatitis.
    Czaja AJ
    Clin Liver Dis; 2015 Feb; 19(1):57-79. PubMed ID: 25454297
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review and meta-analysis of second-line immunosuppressants for autoimmune hepatitis treatment.
    De Lemos-Bonotto M; Valle-Tovo C; Costabeber AM; Mattos AA; Azeredo-da-Silva ALF
    Eur J Gastroenterol Hepatol; 2018 Feb; 30(2):212-216. PubMed ID: 29227329
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ursodeoxycholic acid as adjunctive therapy for problematic type 1 autoimmune hepatitis: a randomized placebo-controlled treatment trial.
    Czaja AJ; Carpenter HA; Lindor KD
    Hepatology; 1999 Dec; 30(6):1381-6. PubMed ID: 10573515
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drug choices in autoimmune hepatitis: part A--Steroids.
    Czaja AJ
    Expert Rev Gastroenterol Hepatol; 2012 Sep; 6(5):603-15. PubMed ID: 23061711
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Autoimmune hepatitis: new diagnostic and therapeutic approach].
    Prelipcean CC; Mihai C; Stefănescu C; Drug VL
    Rev Med Chir Soc Med Nat Iasi; 2004; 108(1):32-9. PubMed ID: 15688753
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Liver fibrosis may reduce the efficacy of budesonide in the treatment of autoimmune hepatitis and overlap syndrome.
    Efe C; Ozaslan E; Kav T; Purnak T; Shorbagi A; Ozkayar O; Berlot AH; Sökmensuer C; Muratori P
    Autoimmun Rev; 2012 Mar; 11(5):330-4. PubMed ID: 22001521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comparison of budesonide and prednisone for the treatment of active pediatric Crohn disease.
    Levine A; Weizman Z; Broide E; Shamir R; Shaoul R; Pacht A; Dinari G; On A; Weiss B; Bujanover Y;
    J Pediatr Gastroenterol Nutr; 2003 Feb; 36(2):248-52. PubMed ID: 12548062
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Autoimmune hepatitis in southern Israel: a 15-year multicenter study.
    Delgado JS; Vodonos A; Malnick S; Kriger O; Wilkof-Segev R; Delgado B; Novack V; Rosenthal A; Menachem Y; Melzer E; Fich A
    J Dig Dis; 2013 Nov; 14(11):611-8. PubMed ID: 23815477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The efficacy and adverse effects of budesonide in remission induction treatment of autoimmune hepatitis: a retrospective study.
    Binicier OB; Günay S
    Croat Med J; 2019 Aug; 60(4):345-351. PubMed ID: 31483120
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.
    Díaz-González Á; Hernández-Guerra M; Pérez-Medrano I; Sapena V; Riveiro-Barciela M; Barreira-Díaz A; Gómez E; Morillas RM; Del Barrio M; Escudé L; Mateos B; Horta D; Gómez J; Conde I; Ferre-Aracil C; El Hajra I; Arencibía A; Zamora J; Fernández A; Salcedo M; Molina E; Soria A; Estévez P; López C; Álvarez-Navascúes C; García-Retortillo M; Crespo J; Londoño MC;
    Hepatology; 2023 Apr; 77(4):1095-1105. PubMed ID: 36626622
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Budesonide versus prednisone in the treatment of active Crohn's disease. The Israeli Budesonide Study Group.
    Bar-Meir S; Chowers Y; Lavy A; Abramovitch D; Sternberg A; Leichtmann G; Reshef R; Odes S; Moshkovitz M; Bruck R; Eliakim R; Maoz E; Mittmann U
    Gastroenterology; 1998 Oct; 115(4):835-40. PubMed ID: 9753485
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management.
    Rizvi S; Gawrieh S
    Drugs Aging; 2018 Jul; 35(7):589-602. PubMed ID: 29971609
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and bone effects of budesonide in primary biliary cirrhosis.
    Rautiainen H; Färkkilä M; Neuvonen M; Sane T; Karvonen AL; Nurmi H; Kärkkäinen P; Neuvonen PJ; Backman JT
    Aliment Pharmacol Ther; 2006 Dec; 24(11-12):1545-52. PubMed ID: 17206943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapeutic effects of azathioprine in combination with low-dose prednisolone in patients with intractable autoimmune hepatitis type 1.
    Takenami T; Sakaguchi K; Nishimura M; Miyake Y; Miyashita M; Terao M; Fujiwara A; Tsuji T
    Acta Med Okayama; 2001 Dec; 55(6):341-7. PubMed ID: 11779096
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of budesonide by means of the Turbuhaler on the hypothalmic-pituitary-adrenal axis in asthmatic subjects: a dose-response study.
    Aaronson D; Kaiser H; Dockhorn R; Findlay S; Korenblat P; Thorsson L; Källén A
    J Allergy Clin Immunol; 1998 Mar; 101(3):312-9. PubMed ID: 9525445
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug therapy in the management of type 1 autoimmune hepatitis.
    Czaja AJ
    Drugs; 1999 Jan; 57(1):49-68. PubMed ID: 9951951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [3rd place in the competition of scientific work in hepatology in 2010. Treatment of patients with overlap of primary biliary cirrhosis and autoimmune hepatitis].
    Golovanova EV
    Eksp Klin Gastroenterol; 2011; (9):140-8. PubMed ID: 22629792
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Infrequent but serious: autoimmune hepatitis and primary biliary cirrhosis. Early therapy improves long-term prognosis].
    MMW Fortschr Med; 2008 Apr; 150(15):45. PubMed ID: 18510120
    [No Abstract]   [Full Text] [Related]  

  • 40. [Autoimmune hepatitis: importance of budesonide in intolerance to prednisolone].
    Audeguy P; Signoret C
    Presse Med; 1999 Jan; 28(4):176. PubMed ID: 10071629
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.